Pancreatic ductal adenocarcinoma (PDAC) is characterized by a high degree of inflammation and profound immune suppression. Here we identify Yes-associated protein (Yap) as a critical regulator of the immunosuppressive microenvironment in both mouse and human PDAC. Within Kras:p53 mutant pancreatic ductal cells, Yap drives the expression and secretion of multiple cytokines/ chemokines, which in turn promote the differentiation and accumulation of myeloid-derived suppressor cells (MDSCs) both in vitro and in vivo. Pancreas-specific knockout of Yap or antibody-mediated depletion of MDSCs promoted macrophage reprogramming, reactivation of T cells, apoptosis of Kras mutant neoplastic ductal cells and pancreatic regeneration after acute pancreatitis. In primary human PDAC, YAP expression levels strongly correlate with an MDSC gene signature, and high expression of YAP or MDSCrelated genes predicts decreased survival in PDAC patients. These results reveal multifaceted roles of YAP in PDAC pathogenesis and underscore its promise as a therapeutic target for this deadly disease.
INTRODUCTION
Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy that accounts for approximately 48 000 new diagnoses and 40 000 deaths in the United States each year. 1 PDAC is commonly diagnosed at an advanced stage and has a five-year survival rate of less than 2%. 1 Precursor lesions, termed pancreatic intraepithelial neoplasia (PanIN), are graded 1-3 with PanIN3 characterized by disorganized growth and prominent nuclear atypia. 2 It is hypothesized that trans-differentiation of acinar cells to duct-like cells, a process termed acinar to ductal metaplasia (ADM), is an initiating event in the development of PanIN. Virtually all PanIN lesions and invasive PDAC involve activating mutations in KRAS. Additional inactivating mutations of tumor suppressor CDKN2A, TP53 or SMAD4 occur commonly in late stage PanINs and PDAC and are associated with a higher metastatic burden. [3] [4] [5] [6] Various genetically engineered mouse models have been developed to reproduce the progression of human PDAC. [7] [8] [9] [10] [11] The model that best mimics the progression of human PDAC involves expression of a mutant Kras (Kras G12D ) from the endogenous Kras locus through a Cre recombinase that is under control of the pancreas-specific promoter p48 (from now on referred to as the KC model). 12 These animals develop ADM with the full spectrum of PanIN lesions that eventually progress to frank PDAC. Concomitant expression of mutated p53 (Trp53 R172H ) with Kras G12D (from now on referred to as the KPC model) accelerates development of precursor lesions and progression to invasive PDAC. 12 The tumor microenvironment of both human and mouse PDAC is characterized by marked desmoplasia and a prominent cellular infiltrate predominantly composed of fibroblasts, leukocytes and endothelial cells. 13 In spite of the presence of tumor infiltrating leukocytes at variable levels, the vast majority of PDAC tumors exhibit profound immune dysfunction due to the recruitment of immunesuppressive leukocytes such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs). [14] [15] [16] [17] [18] [19] [20] [21] Once recruited to the tumor microenvironment, MDSCs and TAMs directly suppress T-cell function by depleting amino acids critical for T-cell activation and proliferation, by producing nitric oxide and reactive oxygen species that suppress T-cell intracellular signaling, and by downregulating selectins required for T-cell homing to lymph nodes. 22 MDSCs and TAMs also indirectly inhibit T-cell activity by secreting suppressive cytokines/chemokines (such as interluekin-6 (IL-6), IL-10 and transforming growth factor-β), which induce regulatory T cells (T reg ) and inhibit the ability of antigen-presenting cells to activate T cells. 22 In PDAC, the massive recruitment of MDSCs and TAMs has also been identified as a potential underlying cause for the relative unresponsiveness of PDAC to T-cell checkpoint inhibitors. 14, 19, [23] [24] [25] We previously identified Yes-associated protein (YAP), a transcriptional coactivator of the TEAD family of transcription factors, as a crucial driver of proliferation in KRAS mutant neoplastic pancreatic ductal cells. 26 We demonstrated that pancreas-specific deletion of Yap in KC and KPC mice completely blocked progression of ADM/PanIN1 into PDAC, resulting in 100% PDAC-free survival. 26 Subsequent studies showed that YAP could also substitute oncogenic KRAS in promoting the growth of PDAC tumors as well as lung adenocarcinomas, 27, 28 and confer resistance to MAPK pathway inhibitors in KRAS or BRAF mutant tumor cells.
inflammation persist in Kras mutant pancreata after caeruleininduced acute pancreatitis, resulting in accelerated PDAC onset. [35] [36] [37] Our previous study showed that inhibition of YAP blocked the expression of multiple secreted factors including IL-6, IL-1α, COX2, MMP7, CTGF and CYR61 by tumor cells, and decreased leukocyte recruitment and desmoplasia. 26 These data suggest that YAP and a YAP-controlled secretome promote the progression of KRAS mutant early precursor lesions to PDAC at least in part by modulating the composition of the tumor microenvironment. Here, we utilize the well-established murine acute pancreatitis model to reveal a novel cancer cell nonautonomous function for YAP in modulating the immune program elicited by oncogenic Kras during the development of PDAC. Our results suggest that YAP acts as a transcriptional driver of cytokines that orchestrate the immunesuppressive microenvironment within PDAC. Figure S1a) . In contrast, ADM and associated desmoplasia, including infiltrates of αSma + fibroblasts and CD45 + leukocytes, remained prevalent at 1-week post-injection in both KPC and KPYC pancreata (Figures 1a and b) . By 5 weeks postinjection, however, KPYC pancreata recovered to nearly normal histological appearance with only remnant Ck19, Vimentin, αSma and CD45 staining, whereas persistent inflammation and progression of ADM to early stage PanINs were evident in KPC pancreata (Figures 1a and b) . While KPC mice started to succumb to PDAC by 9 weeks after caerulein-induced acute pancreatitis, KPYC mice remained PDAC free with fully regenerated pancreata (Supplementary Figure S1b) . These findings suggest that while Yap is not required for initiating ADM and inflammation in response to caerulein, its activity is indispensable for sustaining extended inflammation and preventing regeneration in Kras:Trp53 mutant pancreata.
RESULTS

Yap
Deletion of Yap reactivates T cells and promotes apoptosis of Kras:
Trp53 mutant neoplastic ducts following acute pancreatitis Parenchymal apoptosis is a necessary step that precedes pancreatic regeneration following acute pancreatitis. 38 We found that at 1-week post caerulein injection, KPYC but not KPC pancreata exhibited robust cleaved Caspase 3 staining, particularly within regions of ADM (Figure 2a) . We previously showed that Yap ablation alone did not induce apoptosis in Kras:Trp53 mutant pancreatic ductal cells, 26 suggesting that Yap prevented apoptosis in KPC pancreata following acute pancreatitis possibly by modulating the inflammatory response.
Given the well-established function of T cells in inducing target cell apoptosis, we examined the percentage of CD3 + T cells among the infiltrating CD45 + leukocytes in KPC and KPYC pancreata. In situ immunohistochemistry (IHC) as well as ex vivo flow cytometry analysis demonstrated that infiltrating T cells were abundant in both KPC and KPYC pancreata at 1 week after caerulein treatment, the total numbers of T cells and the ratio of CD4 + T-helper (Th) to Yap inactivation enhances infiltration of MHCII+ macrophages in Kras:Trp53 mutant pancreata following acute pancreatitis As antigen presentation is an essential step in T-cell activation, we next examined the expression of major histocompatibility class II (MHCII) molecules, which are predominantly expressed on the surface of antigen-presenting cells including dendritic cells, B-cells and macrophages. IHC analysis showed a significant increase in the total number of MHCII + cells in the pancreata of KPYC mice compared with KPC mice at 1-week post caerulein injection (Figure 3a) . Moreover, MHCII + cells were present throughout the entire pancreas and in close proximity to CD3 + T cells in KPYC pancreata, whereas they were mostly concentrated in the periphery of the pancreas and rarely in contact with CD3 + T cells in KPC pancreata (Figure 3a ). We observed a significant increase in the total number of F4/80 + macrophages as well as an increase in the proportion of F4/80 + macrophages that express MHCII in KPYC pancreata compared with KPC pancreata (Figures 3a-c and Supplementary Figures S4a and b (Figure 3a) . The macrophages isolated from KPYC pancreata also expressed more iNos (Nos2) and lower levels of Arginase (Arg) compared with those from KPC pancreata, suggesting that macrophages adopted a more antitumorigenic phenotype in KPYC pancreata, while the phenotype of KPC macrophages were primarily tumor-promoting (Figure 3f ). 15 Yap inactivation blocks accumulation of MDSCs in the spleens and pancreata of Kras:Trp53 mutant mice following acute pancreatitis Gr1 +
CD11b
+ MDSCs have been identified in a series of studies as a major immunesuppressive cell population within KPC PDAC tumors that are capable of suppressing T-cell activity both in vitro and in vivo. stimulating factors, IL-6, IL-1β, prostaglandin E2, Tnfα and vascular endothelial growth factor. 22, 39 Previous studies demonstrated that conditioned media (CM) from KPC PDAC cells were able to induce differentiation of myeloid progenitor cells into functional MDSCs capable of suppressing T cells. 14, 19 To examine whether Yap drives the expression of MDSCpolarizing factors by KPC tumor cells, we incubated bone marrow isolated from WT animals with CM from KPYC cells transduced with either vector control or Flag-Yap. 26 As shown in Figure 4d , reconstitution of Yap in KPYC tumor cells rescued the ability of these cells to drive differentiation of the bone marrow-derived myeloid progenitor cells into MDSCs. Of note, CM from Yap reexpressing KPYC cells did not affect the survival of differentiated MDSCs or induce differentiation of MDSC into macrophages or + cytotoxic T cells isolated from pancreata of 9-week-old KPC (n = 3) and KPYC (n = 4) mice at 1 week post caerulein challenge as determined by qRT-PCR. Error bars indicate s.e. ***P o0.0005. (f) Heatmap of relative mRNA expression of genes involved in TCR signaling in pancreata from 9-week-old KPC and KPYC mice at 1 week post caerulein injections as determined by microarray analysis. NS, not significant. Figures S7a and b) . To confirm Yap's role in mediating the expression of MDSC-polarizing factors, we generated KPC tumor-derived PDAC cell lines stably transduced with either a control empty lentiviral vector (pTRIPZ) or a lentiviral vector expressing Yap shRNA (pTRIPZ-Yapsh) in a doxycycline-inducible system (Supplementary Figure S7c) . Incubation of WT bone marrow with CM from either control or Yapknockdown (YapKD) KPC cells showed that silencing of Yap blocked the ability of KPC tumor cells to drive MDSC polarization from bone marrow-derived myeloid progenitor cells (Supplementary Figure S7d) . These results suggest that Yap mediates the expression of soluble factors that promote MDSC polarization by KPC tumor cells.
dendritic cells (Supplementary
Yap drives the transcription of MDSC-polarizing cytokines in Kras: Trp53 mutant pancreatic ductal cells To identify Yap-regulated secreted factors that are responsible for inducing MDSC polarization, we conducted cytokine/chemokine profiling of the pancreata of WT, KPC and KPYC animals at 1-week post caerulein challenge. Among the cytokines that have previously been implicated in MDSC differentiation and/or recruitment, 22 we detected a significant upregulation of Il-6 (Il6), GM-Csf (Csf2), G-Csf (Csf3), M-Csf (Csf1), Tnfα, Il-3, Kc (Cxcl1), Mip2 (Cxcl2) and Mcp-1 (Ccl2) in KPC pancreata compared with WT control, whereas KPYC pancreata maintained similar levels of the above-mentioned cytokines as those of WT animals ( Figure 5a and Supplementary Figure S3b) . In contrast, both KPC and KPYC pancreata expressed significantly higher levels of Il-1α and Il-9 compared with WT pancreata (Supplementary Figure S3c) , while other cytokines such as Il-1β and Il-12 were not significantly changed in either KPC or KPYC pancreata compared with WT control (Supplementary Figure S3d) .
Multiple cell types within PDAC tumors could be responsible for the expression and secretion of above-mentioned cytokines/chemokines. To determine which cytokines/chemokines were directly secreted by the tumor cells in a Yap-dependent fashion, we carried out cytokine/chemokine profiling of CM from KPC tumor cells carrying inducible Yap shRNA or an empty vector control (Supplementary Figure S7c) . Notably, doxycycline-induced knockdown of Yap specifically reduced the levels of secreted Il-6, G-Csf and M-Csf compared with vector control (Figure 5b ), while the other cytokines/chemokines included in our analysis were not affected (not shown). This finding was corroborated by reexpression of Yap in KPYC cells, which caused a significant increase in Il6, Csf1, Csf2 and Csf3 mRNA levels and in the concentrations of Il-6, G-Csf and M-Csf that were secreted into the medium (Figures 5c and d) .
Yap partners with the Tead/Tef family transcription factors to activate target gene expression. In silico analysis identified several Tead-binding consensus sites within the promoter sequences of the above-mentioned pro-MDSC cytokines. Chromatin immunoprecipitation analysis confirmed that in Kras:Trp53 mutant PDAC cells, endogenous Yap was enriched on the promoter regions of Il6 and Csf1-3 that contained Tead-binding sites but not in the 3′UTR regions that lacked Tead-binding motifs (Figure 5e ). Similar results were obtained using Flag antibodies in KPYC cells reconstituted with empty vector or Flag-tagged Yap (Figure 5f ). Taken together, our data indicate that Il6 and Csf1-3 are transcriptionally controlled by the Yap/Tead complex in Kras:p53 mutant pancreatic ductal cells.
Depletion of MDSCs reactivates T cells and promotes tissue regeneration in Kras:Trp53 mutant pancreata following acute pancreatitis Finally, we investigated whether accumulation of MDSCs was indeed responsible for preventing pancreatic recovery in Kras mutant animals following acute pancreatitis. Eight-week-old ;p48-Cre (KC) mice were first subjected to two consecutive days of caerulein injections, and then treated with either control IgG or αGr1 antibodies over the course of 2 weeks (Figure 6a ). Treatment with αGr1 antibodies but not IgG control induced a variable degree of pancreatic recovery in KC mice (Figure 6b) . Importantly, the extent of recovery inversely correlated with levels of remaining MDSCs in the pancreas (Figure 6b) . Depletion of MDSCs also led to influx of MHCII + cells, many of which were in close contact with CD3 + T cells (Figure 6b ). These results demonstrate that MDSCs limit both pancreatic recovery and accumulation of MHCII + cells within the pancreas following caerulein-induced acute pancreatitis.
High YAP expression levels correlate with high expression of MDSC-related genes and poor survival in human PDAC To assess the clinical relevance of our finding, we analyzed The Cancer Genome Atlas (TCGA) RNAseq data set containing 178 human PDAC samples. First, we performed unsupervised clustering of the patient samples using a group of 40 genes that have 
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been previously linked to MDSC generation, recruitment or function, which segregated the patients into three major groups ( Figure 7a ). As shown in Figure 7b , the patients classified as having a 'high' MDSC gene expression profile expressed significantly higher levels of YAP compared with those with a 'low' MDSC classification, implying that YAP may also drive MDSC recruitment in PDAC patients. Consistent with previous reports, 40, 41 we found that patients whose tumors exhibited a 'high' MDSC-related gene expression profile survived a significantly shorter time than the patients with a 'low' MDSC profile (Figure 7c ). Given the strong correlation between MDSC status and YAP expression, we stratified the same set of TCGA patient samples into three groups based on YAP expression levels. Similar to the MDSC gene signature, higher YAP expression levels strongly correlated with poorer overall survival in PDAC patients (Figure 7d ). While these results do not indicate a causative relationship, they support the potential clinical applicability of our finding that Yap acts as an important driver of MDSCmobilizing cytokines/chemokines in a mouse model of PDAC.
DISCUSSION
Abundant infiltration of immunosuppressive leukocytes such as
MDSCs and TAMs is an early event during PDAC oncogenesis and plays a key role in restraining antitumor immunity. 15 Here we show that the immunosuppressive microenvironment orchestrated by Kras mutant neoplastic ductal cells following induction of acute pancreatitis depends on the transcription regulator Yap. Since its discovery 20 years ago, YAP has been established as an important cell-intrinsic regulator of proliferation, survival and differentiation in response to various environmental cues. 42 Here we demonstrate that Yap also acts extrinsically on the tumor microenvironment as a critical immune regulator in Kras mutant pancreata. Importantly, ablation of Yap alone did not alter the normal kinetics of caerulein-induced acute pancreatitis under WT background. In Kras:Trp53 mutant pancreata, Yap knockout also did not prevent prolonged inflammation and the accompanied global changes in transcription, nor did it completely reverse all the cytokines induced by oncogenic Kras. These results suggest that Yap does not simply function as a general inflammatory promoter, but rather controls the secretion of a distinct subset of oncogenic Kras-induced tumor-promoting cytokines.
Our current study identifies Yap-dependent robust upregulation of secreted Il-6, G-Csf, GM-Csf, M-Csf, Tnfα and Il-3 in KPC pancreata. Our previous data demonstrated that Yap is required for both in vitro and in vivo expression of Cox2, an enzyme that mediates prostaglandin E2 synthesis. 26 All of these cytokines have been previously established as critical mediators of MDSC polarization, 14, 19, 24, 25, [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] suggesting that these cytokines likely function in concert to promote MDSC differentiation under the direction of Yap. In addition to regulating the above-mentioned MDSC-polarizing cytokines, we found that in vivo deletion of Yap in Kras:Trp53 mutant pancreatic epithelial cells abrogated the accumulation of several MDSC-attracting cytokines including Kc (Cxcl1), Mip2 (Cxcl2) and Mcp-1 (Ccl2) in the pancreas. 54, 55 Interestingly, a recent study showed that YAP mediates the expression of CXCL5 by prostate tumor cells, which is responsible for attracting MDSCs to the tumor site. 56 Thus, Yap-mediated tumor secretomes may not only affect MDSC differentiation from myeloid progenitor cells but also promote their recruitment to the tumor microenvironment (Figure 8 ).
Like MDSCs, TAMs can also suppress productive antitumor immunity and have been associated with a poor prognosis in many types of cancer, including PDAC. 57 We found that the dramatic decrease in the MDSC population in KPYC pancreata was accompanied by a reciprocal increase in the percentage of MHCII + F4/80 + macrophages. Not only did the overall numbers of MHCII + F4/80 + macrophages increase significantly in KPYC pancreata, but also exhibited enhanced tissue infiltration, increased contact with CD3 + T cells and increased expression of iNos2 with a concomitant decrease in Arginase expression, suggesting that deletion of Yap induced reprograming of TAMs from a tumorpromoting to tumor-suppressing phenotype. Interestingly, the effects of Yap ablation on TAMs are reminiscent of that of Csf1/Csf1R blockade, which caused similar skewing of MHCII low to MHCII high macrophages and bolstered antitumor T-cell responses. 25, 58 These data suggest that Yap may promote recruitment of MDSC and tumor-promoting TAM in part by activating Csf1R signaling.
It remains to be determined how Yap ablation causes concomitant accumulation of MHCII + F4/80 + cell population while decreasing MDSC recruitment, considering that many of the Yap-controlled cytokines such as Csfs, Il-6, and Ccl2 drive the differentiation and recruitment of both MDSC and macrophages. [59] [60] [61] [62] [63] [64] A recent study has shown that during prolonged pancreatitis, IL-4/IL-13 signaling drives alternatively activation of macrophages at least in part by promoting the proliferation of either tissue resident macrophages or recruited monocytes that differentiated to macrophage. 65 In support of this scenario, we find that KPYC pancreata exhibit increased Il-4 and Il-13 expression compared with KPC pancreata at 1-week post caerulein treatment. Besides Il-4 and Il13, KPYC pancreata also express elevated Mip-1a (Ccl3) and Il-7 compared with KPC pancreata. Interestingly, both Mip-1a and Il-7 have been previously shown to stimulate macrophage maturation/tumoricidal activity. [66] [67] [68] Therefore, it would be interesting in the future to elucidate the mechanisms by which Yap modulates the expression of Il-4, Il-7, Il-13 and Mip-1a (Ccl3), and determine which factors are responsible for driving the macrophage reactivation in KPYC pancreata.
Given the rapidly accumulating evidence supporting the critical importance of YAP in many types of human cancer, efforts are underway to develop therapeutic inhibitors against YAP. 69 In agreement with our results from the mouse model, we find that YAP expression levels strongly correlate with those of MDSC signature genes and both high YAP levels and high expression of MDSC-related genes predict poor survival in PDAC patients. These result suggest that successful blockade of YAP in pancreatic cancer has the potential to not only inhibit tumor cell proliferation but also relieve immune suppression within the tumor microenvironment. As YAP functions as a master regulator of many soluble factors that inhibit the antitumor immune response, inhibition of YAP is expected to circumvent the redundancy issues that limit the efficacy of inhibitors that target individual cytokines or receptors. By alleviating MDSC and TAM-mediated immune suppression, inhibition of YAP may also enhance the effectiveness of T-cell checkpoint inhibitors, which in contrast to other solid tumors, have had limited clinical activity in pancreatic cancer.
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MATERIALS AND METHODS Animals
Genetically engineered mouse strains Yap flox/flox , LSL-Kras
G12D
, LSLTrp53 R172H and p48-Cre were interbred to generate all experimental cohorts as described previously. 26, [73] [74] [75] All animal experiments were conducted in compliance with ethical regulations according to protocol #14-052 approved by the Institutional Animal Care and Use Committee at Georgetown University. Acute pancreatitis was induced in 2-month-old mice by injecting caerulein (50 mg/kg) six times with 1-h intervals via i.p for two consecutive days. At 2 days, 1 week and 5 weeks after the first injection, the mice were killed and the entire pancreas was dissected and processed for RNA and protein extractions, or fixing in 10% formalin. At least three mice were used for each time point for each genotype. Both males and females were included in the study without blinding or randomization.
In vivo MDSC depletion assay Two-month-old KC mice were injected with Gr1 antibody or control rat IgG (Bio X Cell, West Lebanon, NH, USA; 250 mg/mouse) via i.p. injection for 3 days prior to initiation of caerulein treatment, after which injections with Gr1 antibody or rat IgG control were performed twice per week for 2 weeks in total.
Cytokine profiling At 1-week post caerulein injections, WT, KPC and KPYC mice were killed and the pancreas was extracted in phospate-buffered saline+0.5%Tween +protease inhibitor cocktail (Roche, Basel, Switzerland) and normalized to 5 mg/ml final concentration. Condition media (CM) from KPC and KPYC lines were collected after cultured in their respective growth medium for 48 h. All samples were stored in − 80°C and shipped on dry ice to Eve Technologies (Calgary, Alberta, Canada) for Mouse Cytokine Yes-associated protein mediates immune reprogramming S Murakami et al Array/Chemokine Array 31-Plex discovery assay. At least three biological repeats were included for each genotype or cell type.
Flow cytometry and immune cell isolation
Pancreata and spleens were harvested at indicated time points and mechanically disrupted in RPMI. Pancreata were then subjected to enzymatic digestion using RPMI+10% fetal bovine serum+3.6 mg/ml collagenase D (Roche). Red blood cells from both pancreata and spleens were lysed using red blood cell lysing solution (eBioscience, San Diego, CA, USA) and the resultant suspension was filtered using a 70-μm cell strainer to remove any resultant debris. Cells were then stained for intracellular and surface antigens as previously described. 76 The following antibodies were used for surface antigen staining:CD45 (Biolegend, San Diego, CA, USA; clone 30-F11), CD4 (eBioscience; clone RM4-5), CD8a (Biolegend; clone 53 . Data are represented by mean of all replicates within the genotypes. Primer sequences of the genes analyzed are listed in Supplementary Table S1 .
IHC/IF
IHC was performed with formalin-fixed and paraffin-embedded mouse pancreas sections as previously described. 26 Immunofluorescence was performed after blocking in appropriate serum, followed by incubation overnight with primary antibodies at 4°C. Next day, slides were washed and incubated with HRP-or fluorescein-conjugated secondary antibodies for 30 min, and in the case when HRP-conjugated secondary antibodies were used, subjected to signal amplification with Tyramide signal amplification detection kits (Thermo Fisher Scientific, Waltham, WA, USA) according to the manufacturers' instruction. The slides were incubated with Sudan black (AMRESCO, Solon, OH, USA) for 5 min to suppress autofluorescence and then mounted by mounting solution containing Hoechst33342. Confocal fluorescent images were obtained by a Zeiss LSM 510 Meta confocal microscope (Jena, Germany) and processed with ImageJ software (Bethesda, MD, USA). All the quantification of signal intensity or area from IHC and immunofluorescence was performed with ImageJ and data from at least five slides/fields were averaged. The following antibodies were used for IHC and immunofluorescence: CK19 (DHSB, Iowa City, IA, USA), Vimentin (Abcam, Cambridge, UK), αSMA (Abcam), Cleaved Caspase 3 (Cell signaling Technology, Danvers, MA, USA), CD3 (Dako, Glostrup, Denmark), CD45 (BD Biosciences), CD44 (BioLegend), GZMB (Abcam), MHCII (Biolegend), F4/80 (eBioscience), Gr1 (Bio X cell), Ly6G (BD Biosciences) and Ly6C (Abcam).
Cell culture KPC/vector and KPYC/Flag-Yap lines were established previously and cultured on collagen-coated plates in Waymouth MB 752/1 medium (Sigma-Aldrich, St Louis, MO, USA) containing 10% fetal bovine serum. 26 KPC cells established from a KPC PDAC tumor were stably transduced with pTRIPZ or pTRIPZ-Yapsh and maintained in DMEM medium (Corning, Corning, NY, USA) containing 10% fetal bovine serum. Yapsh expression was induced by treating the cells with Doxcycline (4 μg/ml) for 3 days. Regularly mycoplasma testing was performed in house using Mycoplasma Detection Kit (InvivoGen, San Diego, CA, USA).
In vitro MDSC differentiation and survival assay WT mice were killed by CO 2 inhalation and femurs were collected. Bone marrow cells were flushed out with phospate-buffered saline and passed through a 28 G needle. 
Western blotting
Cells were lysed with urea buffer (9.5 M urea, 2% CHAPS). Aliquots of cell lysates were heated at 95°C for 5 min and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The following primary and secondary antibodies were used: anti-Yap antibody (Cell Signaling), antiactin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-rabbit IgG conjugated with horseradish peroxidase (Cell Signaling Technology) and anti-mouse IgG conjugated with horseradish peroxidase (Cell Signaling Technology).
Chromatin immunoprecipitation
Chromatin immunoprecipitation analysis was performed as previously described using normal rabbit IgG (Santa Cruz Biotechnology; Sc-2027X), antibodies against Yap (Santa Cruz Biotechnology; Sc-15407X) and Pol II (Santa Cruz Biotechnology; Sc-899X). 26 Immunoprecipitated DNA was eluted and amplified using qRT-PCR with primer pairs flanking different promoter regions of the mouse Lif, Il6, Csf1, Csf2 and Csf3 genes that contain putative Tead-binding sites. The primer sequences used in the study are listed in Supplementary Table S1 .
Microarray analysis
Snap-frozen pancreas tissues were grounded and total mRNAs were isolated using RNeasy mini kits (Qiagen). mRNA samples that passed quality check were amplified, labeled and hybridized to Illumina MouseRef-8 v2.0 Expression BeadChips at the UCLA Neuroscience Genomics Core (Los Angeles, CA, USA). Intensity data were background corrected and normalized, and unsupervised clustering was performed in R using the limma package from Bioconductor. The GSEA Java-based software package from The Broad Institute (Cambridge, MA, USA) was used to determine enrichment scores, significance of enrichment and to generate enrichment plots.
TCGA analysis
The TCGA PDAC RNAseq V2 data set and associated clinical data were downloaded and processed in R. Samples were filtered to only those that were derived from tumor, based on TCGA barcoding. A group of 40 MDSC-related genes based on published literature were used to perform hierarchical clustering (Ward) on the Manhattan distance matrix between all filtered samples. The produced clustering was cut based on observable grouping. Samples with associated clinical data were used to produce survival curves in R/Prism using the R survival package. Only samples with overall survival 430 days were used to minimize effects from surgeries.
Statistical analysis
Minimum of three mice or independent samples were used for all the experiments unless otherwise indicated. All experiments shown were replicated at least three times or in three unique samples. Student's t-test was used to determine significance unless otherwise indicated. Significance is defined as a P-value of 0.05 or less. Error bars on all graphs are standard error of the mean or standard deviation as indicated.
